Ovintiv
At a glance
Ovintiv reported 2025 revenue of $8.66B, down 3.1% from $8.94B in 2024. Over 4 years since 2021 ($10.47B), that is a decline of about 4.6% a year. Operating margin was 13.1%, down from 14.5% in 2021. Revenue peaked in 2022 at $14.26B.
In the last 12 months 5 insiders reported 0 open-market purchases and 6 sales ($5.7M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $2.1M by EVP & COO Gregory Dean Givens on Dec 8, 2025.
Ovintiv filed 24 current reports (Form 8-K) in the last 12 months, most often for regulation fd disclosure (9), material agreement (4), results of operations (4) and officer or director change (3). The latest officer or director change was reported on Feb 20, 2026. It reported a material agreement or a completed acquisition or disposal 6 times.
2 of the 20 investors tracked here held Ovintiv at the last quarter end, worth $63M combined. It is the largest weight for Bridgewater Associates (0.2% of its portfolio), followed by Renaissance Technologies (0%). Added: Bridgewater Associates and Renaissance Technologies.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $1.42B | $3.64B | $2.08B | $1.13B | $1.24B |
| Diluted EPS | $5.32 | $14.08 | $7.90 | $4.21 | $4.78 |
| Dividend per share | $0.47 | $0.95 | $1.15 | $1.20 | $1.20 |
Fiscal year ends Dec 31 · incorporated in DE
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined